JP2018538292A5 - - Google Patents

Download PDF

Info

Publication number
JP2018538292A5
JP2018538292A5 JP2018529981A JP2018529981A JP2018538292A5 JP 2018538292 A5 JP2018538292 A5 JP 2018538292A5 JP 2018529981 A JP2018529981 A JP 2018529981A JP 2018529981 A JP2018529981 A JP 2018529981A JP 2018538292 A5 JP2018538292 A5 JP 2018538292A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
cancer
solvate
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018529981A
Other languages
English (en)
Japanese (ja)
Other versions
JP6867652B2 (ja
JP2018538292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/080453 external-priority patent/WO2017097986A1/en
Publication of JP2018538292A publication Critical patent/JP2018538292A/ja
Publication of JP2018538292A5 publication Critical patent/JP2018538292A5/ja
Application granted granted Critical
Publication of JP6867652B2 publication Critical patent/JP6867652B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018529981A 2015-12-09 2016-12-09 癌療法のためのモノマレイミド官能化白金化合物 Expired - Fee Related JP6867652B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15198739 2015-12-09
EP15198739.3 2015-12-09
PCT/EP2016/080453 WO2017097986A1 (en) 2015-12-09 2016-12-09 Monomaleimide-functionalized platinum compounds for cancer therapy

Publications (3)

Publication Number Publication Date
JP2018538292A JP2018538292A (ja) 2018-12-27
JP2018538292A5 true JP2018538292A5 (cg-RX-API-DMAC10.html) 2020-01-23
JP6867652B2 JP6867652B2 (ja) 2021-05-12

Family

ID=54849106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018529981A Expired - Fee Related JP6867652B2 (ja) 2015-12-09 2016-12-09 癌療法のためのモノマレイミド官能化白金化合物

Country Status (21)

Country Link
US (2) US10723748B2 (cg-RX-API-DMAC10.html)
EP (1) EP3386997B1 (cg-RX-API-DMAC10.html)
JP (1) JP6867652B2 (cg-RX-API-DMAC10.html)
CN (1) CN108368143B (cg-RX-API-DMAC10.html)
AU (1) AU2016367306B2 (cg-RX-API-DMAC10.html)
CA (1) CA3004630A1 (cg-RX-API-DMAC10.html)
CY (1) CY1124529T1 (cg-RX-API-DMAC10.html)
DK (1) DK3386997T3 (cg-RX-API-DMAC10.html)
ES (1) ES2898704T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20211466T1 (cg-RX-API-DMAC10.html)
HU (1) HUE056897T2 (cg-RX-API-DMAC10.html)
IL (1) IL259864B (cg-RX-API-DMAC10.html)
LT (1) LT3386997T (cg-RX-API-DMAC10.html)
MX (1) MX377528B (cg-RX-API-DMAC10.html)
PL (1) PL3386997T3 (cg-RX-API-DMAC10.html)
PT (1) PT3386997T (cg-RX-API-DMAC10.html)
RS (1) RS62412B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201804885TA (cg-RX-API-DMAC10.html)
SI (1) SI3386997T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202100709T1 (cg-RX-API-DMAC10.html)
WO (1) WO2017097986A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016030310A2 (pt) * 2014-06-23 2017-08-22 Placon Therapeutics Inc Compostos de platina, composições e seus usos
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN109171001A (zh) * 2018-09-14 2019-01-11 上海烟草集团有限责任公司 草酸钠在降低卷烟烟气中TSNAs释放量中的应用
WO2021138215A1 (en) * 2019-12-31 2021-07-08 Kinnate Biopharma Inc. Treatment of cancer with cdk12/13 inhibitors
CN114163479B (zh) * 2020-09-11 2025-05-16 上海海聚生物科技有限公司 一类治疗癌症用的铂类化合物及其制备方法
US20230339997A1 (en) * 2020-09-11 2023-10-26 Shanghai Haiju Biological Technology Co., Ltd. Class of platinum compounds for treating cancer, and method for preparation thereof
CN114539320B (zh) * 2020-11-25 2026-01-27 北京大学 辐射激活的四价铂配合物及其用途
WO2026132589A1 (en) 2024-12-19 2026-06-25 Universität Wien Egfr inhibitor-functionalized albumin-binding platinum compounds for cancer therapy

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CH605550A5 (cg-RX-API-DMAC10.html) 1972-06-08 1978-09-29 Research Corp
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
JPS607934A (ja) 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造方法
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3486459D1 (de) 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
CS269719B1 (en) 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
DE19636889A1 (de) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
ATE248583T1 (de) 1997-09-29 2003-09-15 Nektar Therapeutics In dosierinhalatoren verwendbare, stabilisierte zubereitungen
CA2326389C (en) 1998-04-21 2007-01-23 Micromet Gesellschaft Fur Biomedizinische Forschung Mbh Novel cd19xcd3 specific polypeptides and uses thereof
DE19926154A1 (de) 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
DE10314780A1 (de) 2003-03-19 2004-09-30 Ktb Tumorforschungsgesellschaft Mbh Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
JP2006521300A (ja) 2003-03-31 2006-09-21 プリヴァ−ラケマ,エー.エス. 活性物質として白金錯体を含有する医薬組成物およびその製造方法
CZ296169B6 (cs) 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
US20060205810A1 (en) 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations
CZ300424B6 (cs) 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300590B6 (cs) 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
BR112014013526A8 (pt) 2011-12-05 2017-06-13 Igenica Biotherapeutics Inc conjugados de anticorpo-fármaco e compostos, composições e métodos relacionados
CN104302408B (zh) * 2012-02-27 2016-12-14 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
WO2015052516A1 (en) * 2013-10-08 2015-04-16 Atlas Genetics Limited Labelling compounds and their use in assays
EP3089745A4 (en) 2013-12-31 2017-05-17 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
BR112016030310A2 (pt) * 2014-06-23 2017-08-22 Placon Therapeutics Inc Compostos de platina, composições e seus usos
US10342801B2 (en) 2015-06-23 2019-07-09 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
US20180186823A1 (en) 2015-06-23 2018-07-05 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
WO2017004123A1 (en) 2015-06-29 2017-01-05 Case Western Reserve University Anticancer drug-containing plant virus particles
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
JP7043425B2 (ja) 2016-06-06 2022-03-29 ジェネンテック, インコーポレイテッド シルベストロール抗体-薬物コンジュゲート及び使用方法
JP2019524706A (ja) 2016-07-08 2019-09-05 ジェネンテック, インコーポレイテッド Muc16陽性癌治療の応答性を評価するためのヒト精巣上体タンパク質4(he4)の使用
WO2018026742A1 (en) 2016-08-01 2018-02-08 Askgene Pharma Inc. Novel antibody-albumin-drug conjugates (aadc) and methods for using them
CN108164512B (zh) 2017-12-27 2021-05-25 沈阳药科大学 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用
CN108187063B (zh) 2018-01-09 2020-09-08 沈阳药科大学 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药

Similar Documents

Publication Publication Date Title
JP2018138577A5 (cg-RX-API-DMAC10.html)
JP2020533277A5 (cg-RX-API-DMAC10.html)
JP2013522292A5 (cg-RX-API-DMAC10.html)
JP2020518669A5 (cg-RX-API-DMAC10.html)
JP2017530171A5 (cg-RX-API-DMAC10.html)
JP2018511590A5 (cg-RX-API-DMAC10.html)
RU2019121922A (ru) Композиции и способы лечения рака
NZ603654A (en) Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
JP2019535744A5 (cg-RX-API-DMAC10.html)
JP2019512478A5 (cg-RX-API-DMAC10.html)
JP2019511483A5 (cg-RX-API-DMAC10.html)
JP2019508496A5 (cg-RX-API-DMAC10.html)
JP2023510737A5 (cg-RX-API-DMAC10.html)
JP2014528480A5 (cg-RX-API-DMAC10.html)
JP2017538677A5 (cg-RX-API-DMAC10.html)
HRP20211466T1 (hr) Spojevi platine funkcionalizirani monomaleimidom, namijenjeni terapiji raka
JP2022071077A5 (cg-RX-API-DMAC10.html)
JP2017526662A5 (cg-RX-API-DMAC10.html)
JP2013520502A5 (cg-RX-API-DMAC10.html)
JP2019502675A5 (cg-RX-API-DMAC10.html)
JP2010540556A5 (cg-RX-API-DMAC10.html)
JP2014504646A5 (cg-RX-API-DMAC10.html)
JP2023510736A5 (cg-RX-API-DMAC10.html)
JP2022548250A5 (cg-RX-API-DMAC10.html)
JP2015522656A5 (cg-RX-API-DMAC10.html)